The World Health Organization (WHO) recommends that the persons who were evacuated against the covid-19 received the dose of the same manufacturer, and as such they are receiving first one of the development by Pfizer-BioNTech the second también sea of its pharmaceutical.
“I would like to have practical considerations, in some cases in which there is no other option to seriously evacuate with different products to make, but in principle we do not recommend it”, said the Director of Immunization of the WHO, Kate O’Brian in a meeting on social media.
In the same forum, the Mexican Alejandro Cravioto, president of the Strategic Assessor Group of Experts who study the new vacancies for the OMS, added that it is recommended not to receive vacancies against other patients until the last week to receive the destination a protector against the coronavirus SARS-CoV-2.
Cravioto also claims that there is evidence that the most likely secondary effects of these vacancies are in the mayor’s office less often than in the other youths.
“We do not have any reason to think that the vaccine can be judged by the mayors of 65 years”, insists Cravioto.
According to these experts, the secondary effect observed most with some allergic reactions, because the centers that administer the vaccine are capable of treating these anaphylactic shocks of intermediates.
Another effect observed in very small numbers of patients in those undergoing clinical trials is cases of facial paralysis that do not last, fever or general malaise, which are not considered reasons for not receiving the vaccine.